These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30285971)

  • 1. Blood Products in the Management of Abnormal Placentation.
    Gatta LA; Lockhart EL; James AH
    Clin Obstet Gynecol; 2018 Dec; 61(4):828-840. PubMed ID: 30285971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anesthetic management of patients with placenta accreta and resuscitation strategies for associated massive hemorrhage.
    Snegovskikh D; Clebone A; Norwitz E
    Curr Opin Anaesthesiol; 2011 Jun; 24(3):274-81. PubMed ID: 21494133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major obstetric hemorrhage.
    Le Gouez A; Mercier FJ
    Transfus Clin Biol; 2016 Nov; 23(4):229-232. PubMed ID: 27592155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-partum haemorrhage from the lower uterine segment secondary to placenta praevia/accreta: successful conservative management with Foley balloon tamponade.
    Albayrak M; Ozdemir I; Koc O; Demiraran Y
    Aust N Z J Obstet Gynaecol; 2011 Aug; 51(4):377-80. PubMed ID: 21806571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous blood transfusion in patients with placenta previa.
    Yamada T; Mori H; Ueki M
    Acta Obstet Gynecol Scand; 2005 Mar; 84(3):255-9. PubMed ID: 15715533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How do we manage blood product support in the massively hemorrhaging obstetric patient?
    O'Brien KL; Uhl L
    Transfusion; 2016 Sep; 56(9):2165-71. PubMed ID: 27488384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on the use of massive transfusion protocols in obstetrics.
    Pacheco LD; Saade GR; Costantine MM; Clark SL; Hankins GD
    Am J Obstet Gynecol; 2016 Mar; 214(3):340-4. PubMed ID: 26348379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Standardized Approach for Transfusion Medicine Support in Patients With Morbidly Adherent Placenta.
    Panigrahi AK; Yeaton-Massey A; Bakhtary S; Andrews J; Lyell DJ; Butwick AJ; Goodnough LT
    Anesth Analg; 2017 Aug; 125(2):603-608. PubMed ID: 28640786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using recombinant activated factor VII, B-Lynch compression, and reversible embolization of the uterine arteries for treatment of severe conservatively intractable postpartum hemorrhage: new method for management of massive hemorrhage in cases of placenta increta.
    Mechsner S; Baessler K; Brunne B; Albrecht T; Hopp H; Dudenhausen JW
    Fertil Steril; 2008 Nov; 90(5):2012.e1-5. PubMed ID: 18462726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Massive obstetric hemorrhage: Current approach to management.
    Guasch E; Gilsanz F
    Med Intensiva; 2016; 40(5):298-310. PubMed ID: 27184441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion Medicine in a Multidisciplinary Approach to Morbidly Adherent Placenta: Preparing for and Preventing the Worst.
    DeSimone RA; Leung WK; Schwartz J
    Transfus Med Rev; 2018 Oct; 32(4):244-248. PubMed ID: 30025661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical management of placenta accreta: to leave or remove the placenta?
    Perez-Delboy A; Wright JD
    BJOG; 2014 Jan; 121(2):163-9; discussion 169-70. PubMed ID: 24373590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foreword: Management of Abnormal Placentation.
    Silver RM
    Clin Obstet Gynecol; 2018 Dec; 61(4):731-732. PubMed ID: 30312189
    [No Abstract]   [Full Text] [Related]  

  • 14. Utilization and outcomes of massive transfusion protocols in women with and without invasive placentation.
    Shainker S; Shamshirsaz A; Haviland M; O'Brien K; Redhunt A; Bateni Z; Moaddab A; Fox K; Hui SK; Belfort M; Dildy G; Hacker M
    J Matern Fetal Neonatal Med; 2020 Nov; 33(21):3614-3618. PubMed ID: 30821559
    [No Abstract]   [Full Text] [Related]  

  • 15. Conservative management of placenta previa percreta in a Jehovah's Witness.
    Weinstein A; Chandra P; Schiavello H; Fleischer A
    Obstet Gynecol; 2005 May; 105(5 Pt 2):1247-50. PubMed ID: 15863598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The morbidly adherent placenta: an overview of management options.
    Doumouchtsis SK; Arulkumaran S
    Acta Obstet Gynecol Scand; 2010 Sep; 89(9):1126-33. PubMed ID: 20804337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting-edge advances in the medical management of obstetrical hemorrhage.
    Pacheco LD; Saade GR; Gei AF; Hankins GD
    Am J Obstet Gynecol; 2011 Dec; 205(6):526-32. PubMed ID: 21816382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antenatal diagnosis of placenta accreta leads to reduced blood loss.
    Tikkanen M; Paavonen J; Loukovaara M; Stefanovic V
    Acta Obstet Gynecol Scand; 2011 Oct; 90(10):1140-6. PubMed ID: 21488840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Iliac artery occlusion balloons for suspected placenta accreta during cesarean section].
    Burgos Frías N; Gredilla E; Guasch E; Gilsanz F
    Rev Esp Anestesiol Reanim; 2014 Feb; 61(2):105-8. PubMed ID: 23276376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-Conservation Strategies in a Blood-Refusal Parturient with Placenta Previa and Placenta Percreta.
    Mauritz AA; Dominguez JE; Guinn NR; Gilner J; Habib AS
    A A Case Rep; 2016 Mar; 6(5):111-3. PubMed ID: 26556107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.